Gynecologic Oncology Group: Vulvar Neoplasms trials

The registry lists 11 Vulvar Neoplasms studies with Gynecologic Oncology Group as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 2 3Phase 3 5No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the VulvaStatus unknownNCT01595061Phase 2Results posted
• Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial CancerTerminatedNCT00577317Phase 3Results posted
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the VulvaCompletedNCT00068406Phase 2Results posted
• Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node DissectionStatus unknownNCT01500512
• Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and LymphadenectomyCompletedNCT01406769Phase 2
• Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar CancerStatus unknownNCT00956670Not applicable
• Radiation Therapy or Surgery in Treating Patients With Previously Untreated Vulva Cancer With Positive Groin Lymph NodesCompletedNCT00898352Phase 3
• Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
• Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the VulvaCompletedNCT00028951Phase 3
• Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the VulvaTerminatedNCT00006096Phase 3
• Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the VulvaCompletedNCT00003325Phase 3